|
HS Code |
772216 |
| Iupac Name | 3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one |
| Molecular Formula | C16H24N2O2 |
| Molecular Weight | 276.38 g/mol |
| Appearance | Solid (expected, depends on specific conditions) |
| Solubility | Likely soluble in organic solvents, morpholine moiety increases water solubility |
| Chemical Class | Tetrahydroindolone derivative |
| Functional Groups | Indolone, morpholine, alkyl substituents |
| Structure Features | Fused indole core, morpholine ring at position 5, ethyl at position 3, methyl at position 2 |
| Storage Conditions | Store in a cool, dry place away from light |
As an accredited 3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle with tamper-evident cap, labeled with chemical name, 5g net weight, hazard symbols, and manufacturer details. |
| Shipping | The chemical **3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One** should be shipped in tightly sealed containers, protected from moisture and light. Standard chemical shipping regulations should be followed, with appropriate labeling and documentation. Handle as a laboratory reagent, ensuring compliance with all applicable transport safety guidelines for organic compounds. |
| Storage | 3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from ignition sources, incompatible materials, and direct sunlight. Maintain storage at room temperature, unless otherwise specified, and ensure proper chemical labeling and compliance with safety regulations. |
Applications of 3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One in Industrial ManufacturingAs a specialist chemical manufacturer, we supply 3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One as a high-value intermediate to select industries. Its unique functional groups and structural attributes are regularly adopted in several advanced downstream processes, each governed by stringent compliance, exact usage parameters, controlled process operations, and distinct finished product specifications. 1. Pharmaceutical Intermediate for CNS Drug SynthesisPharmaceutical companies incorporate this tetrahydroindolone derivative as a key intermediate during multi-step syntheses for certain central nervous system (CNS) active small molecules. Its presence in the core structure facilitates the required substitutions and molecular modifications essential for the development of novel neuropsychiatric and neurodegenerative treatment agents. Production lines integrate our material into proprietary synthetic routes under GMP standards, leveraging its stability during scale-up phase chemistry. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Intermediate for Crop Protection Compound SynthesisAgrochemical formulators utilize this molecule as a secondary building block in the production of advanced heterocycle-rich active ingredients for crop protection. Its chemical structure supports the creation of indole-based scaffold systems used in the synthesis of modern fungicides and insecticides, allowing for functional group diversification at strategic process points. Integration occurs under well-controlled batch or continuous reactor settings following ISO and local regulatory standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. API Intermediate for Oncology Research CompoundsResearch-based pharmaceutical manufacturers employ this compound as a tailored precursor in the development of targeted anticancer therapeutics. Its utility emerges in the functionalization and elaboration of tetrahydroindolone moieties linked to kinase inhibitors and receptor antagonists that require precise spatial orientation of side groups. Usage falls under controlled laboratory and pilot scale synthesis, adhering to strict traceability and impurity control protocols to meet investigational new drug (IND) demands. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Intermediate for Advanced Dye and Pigment ManufacturingLeading dye and specialty pigment producers rely on this indole-based intermediate during the synthesis of high-performance, color-stable pigment formulations for niche technical textiles and printing inks. It supports the expansion of novel aromatic core systems to control shade, fastness, and application compatibility. Producers introduce the compound in controlled condensation and cyclization reaction stages, fitting it into robust manufacturing operations aligned with environmental and quality mandates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
From the heavy clank of the reactor lid to the faint trace of new product in the sample room, we know a thing or two about how specialty chemicals change not just industrial formulas, but scientific possibility itself. We develop 3-Ethyl-2-Methyl-5-(Morpholin-4-Ylmethyl)-1,5,6,7-Tetrahydroindol-4-One (let's call it “EMMTMI” for ease), because demand doesn’t come out of nowhere. We see researchers asking for cleaner yields and process engineers searching for molecules that handle the thermal load. This compound was not born from marketing plans, but from feedback, bench work, and improvements rooted in methodical experimentation.
Plenty of molecules promise selectivity, purity, or compatibility, but EMMTMI delivers those values every shift. Our team plans each stage—right down to solvent recovery—so consistency stays high. Even seasoned chemists who visit comment on the tight batch results. EMMTMI has gained a reputation for high assay values, minimal byproducts, and a color that signals purity ahead of the actual analytical run. Line workers notice the difference when blending or portioning—the powder moves with a reliable profile, no excessive clumping, no residue that complicates the next cleanout.
After years of working directly with this compound’s synthesis and post-processing, any discrepancy in melting point or spectral match shows up fast. The standard we release—EMMTMI Model: 001—gets scrutinized every lot. Typical output comes as a fine, near-white solid, with optimal moisture control from our nitrogen-protected packaging line. We work with modern HPLC and NMR for every run, and repeated chromatographic purity checks ensure batch-to-batch reproducibility.
Our products leave the facility only when they meet benchmarks honed over the years: high mass balance, absence of troublesome residual solvents, and an impurity profile that does not drift. The team can show calibration records and results, right down to the logbooks filled by staff who sign off on each final drum or bottle.
Spending time with development chemists gave us insights into why EMMTMI earns repeat orders. This compound supports both research and advanced manufacturing, favored for its core scaffold and specific morpholine function. Pharmaceutical R&D looks for intermediates that behave, not just on paper, but under pressure from both regulators and reactors. EMMTMI answers this, giving synthetic routes a stable, reliable intermediate that tolerates downstream modification.
Some teams use EMMTMI in high-pressure hydrogenations. Others trial its framework for building more complex heterocycles. The morpholine ring imparts solubility and reactivity patterns that open doors where less flexible molecules stall. We work closely with both industrial and academic labs to resolve issues like solubility during scale-up, and customers get our technical support right through their own pilot trials. Our team keeps hearing that documentation for traceability—batch pedigrees, certificates matching analytic results—keeps projects running rather than stalling on compliance checks.
Many compounds arrive with a slick brochure, but chemists want to know that a kilogram of material will look and handle the same way month after month. That is why we have production logs going back years, so people know what to expect. We ship EMMTMI that sticks to the agreed-upon physical properties—not just bulk assay, but flow, moisture, and absence of offensive odors that complicate clean-room protocols. Old-school synthetic chemists point to EMMTMI’s robust performance in filtration setups, no matter what type of glassware or filter porosity they’re using.
Formulation staff trust our process because every reactor wash-down, every purification cycle, every handling test gets logged. You want to know you can run a full reaction profile or downstream process without clogs, unexpected exotherms, or product denaturation. We have seen customers roll out new product lines after finding unexpected stability in their test runs with our EMMTMI material.
We took part in trials where teams bottomed out using alternative tetrahydroindolones—yields would drop, crystalline purity would fluctuate, or timelines stretched. Many of those teams told us that switching to our EMMTMI material brought back reliability. Across several formulation settings—API intermediate assembly, medicinal chemistry, fine chemical crop protection projects—customers send in their results, showing that where substitutions failed, EMMTMI kept up.
Not every batch requires complex process adaptations. For lesser-known molecules, sometimes every kilo feels like a gamble. The purity delta between lots is where scaleups hit trouble. We mitigate that risk, not through advertising but by deeply understanding what drift in melting point or chromatographic tailing might mean for a downstream step. EMMTMI consistently avoids these problems, not by accident, but because we never dilute our process controls or skip raw material validation.
Synthetic pathways can look elegant in a conference poster; what counts is whether a compound stays stable months after delivery, or if the entire drum needs to be scrapped after ambient storage. EMMTMI holds up because every run follows a protocol grounded in real industrial experience. Minor phase transitions, pH drift during workup, and water uptake are all accounted for in our plant layout. Production supervisors keep detailed logs on everything from reaction kinetics to line cleaning, because experience has shown this catches issues long before product ever ships.
A compound with similar backbone but different side chain substitutions won’t always work in the same process. We field technical requests weekly from seasoned chemists asking about the specific impacts of the morpholine group on reactivity and downstream process safety. Others try to swap in a close analog only to find filtration sludges or residue issues they had not expected. EMMTMI’s unique structure, especially the morpholin-4-ylmethyl substitution, offers improved solubility in mixed solvents and a different electronic profile, so certain nucleophilic substitutions and cyclization conditions run more predictably.
Factory workers walk every meter of the production line, because minor problems like valve residue or poorly calibrated pumps translate into headaches for our customers down the road. No remote oversight—every check is made onsite, on schedule. We calibrate our analytical equipment ourselves, train every technician in both standard procedures and creative troubleshooting, and keep records long after the end of batch. This comes from hard-earned lessons: Fielding an emergency call about a brownish tinge in a delivered lot taught us to tighten visual inspection standards. A request for documentation tracing every microgram back to its route through the plant meant a system robust enough to handle regulatory surprise audits.
Some see quality as a moving target. We see it as the sum of repetitive, sometimes tedious habits, driven by fielding the same questions year after year and seeing firsthand the costs when a batch falls short. We know EMMTMI’s integrity can make or break someone’s grant, pilot, or regulatory submission, so we back each unit shipped with documentation and full batch histories. Clients with urgent scaleup needs count on early notification whenever process improvements are made—no surprises, just open lines of communication.
Many intermediates get by in research settings, falling apart when entered into large-volume reactors or subjected to long storage. EMMTMI proves itself in both. Bulk purchasers routinely test stability not in gentle conditions but in ambient storage, aggressive mechanical blending, and extended thermal cycling. The feedback we receive pushes us to test harder, track shelf life with longer studies, and dial in crystallization profiles to ensure that the product arrives uncompromised even after long shipments.
Industrial buyers call out low moisture uptake and consistent handling as reasons EMMTMI remains their preferred intermediate. Quality-control labs run blind checks and consistently report tight compliance with their internal specs, which we believe reflects both the maturity of our process and the efforts of our production staff. The competitive edge isn’t a marketing claim but a result of years pouring over process records and rejecting lots that fall below our threshold.
Scaling up production usually exposes weaknesses in small-batch optimization. Not so with EMMTMI—the kinetic profile remains manageable, the energy load during exothermic steps stays within a predictable window, and post-reaction workup doesn’t introduce new variables. This keeps the plant running efficiently and customers satisfied at every scale.
Materials management teams notice the sifting, weighing, and blending properties hold up, saving time in transfer and reducing loss during storage. The handful of major clients running continuous flow or automated lines have commented that EMMTMI transitions smoothly through inline handling equipment. These seemingly minor details, such as consistent particle size and low electrostatic charge buildup, make the difference between a seamless shift and hours lost to equipment cleaning.
Nobody sees the actual cost of quality control unless they stand in the lab after hours, troubleshooting a reject batch or running re-tests and validations. We do that, because customers expect each unit to meet spec—not “close enough,” but as promised. Our QC staff report directly to production, closing any gap between paperwork and reality. This approach has made EMMTMI a trusted tool across many demanding environments.
One reason EMMTMI maintains a solid track record across chemical and pharmaceutical sectors grows out of our direct involvement with end users. We adjust process parameters in response to detailed user reports, tweak crystallization rates if handling feedback suggests dust concerns, and welcome regular technical audits from partners seeking to onboard a new process intermediate. The cycle of feedback and adjustment defines each production run.
Every major modification feeds right back into the process instructions for the next lot. Open dialogues with buyers, whether in API synthesis, chemical innovation, or downstream fine chemical manufacturing, keep EMMTMI’s relevance high while minimizing the risk of obsolescence. We purposely avoid over-standardizing the product, leaving enough flexibility to accommodate slightly different specification requests—always within the parameters that ensure quality and utility.
Direct comparisons from our partners confirm what years in this business have shown: Substituting another 1,5,6,7-tetrahydroindol-4-one analog often forces a rethink of solvent, temperature, or purification steps. EMMTMI’s particular combination of ethyl, methyl, and morpholine-methyl groups sets it apart in terms of both reactivity and handling. Its solubility profile fits more synthetic routes, letting process chemists adjust fewer other steps. The minimal presence of side byproducts and known shelf stability edge out alternatives when the clock is running on commercial process timelines.
Rather than push a molecule out the door based on crowded chemical catalogs, we listen for real-world usability. If end-users report issues—lumping, yield drift, slow filtration—we bring those details back into the production meeting until the issue is solved. It’s this hands-on, iterative approach that has made EMMTMI a leader in its segment for both reliability and ease of incorporation.
Designing, producing, and supplying a chemical like EMMTMI involves a distinct kind of pride that comes from making the thousandth kilo with the same attention to detail as the first demonstration batch. We believe in sharing technical insight, and every product unit shipped represents a cross-section of years—sometimes decades—of learning, failure, recalibration, and eventual success.
It’s not enough to claim a molecule is “advanced” or “high performance.” The real test comes under the harsh lights of inspection, in the troubleshooting calls from customers with tricky reactors and unpredictable solvents, or in project meetings where process engineers recount which intermediates sailed through scaling and which caused setbacks. Our assurance is rooted in experience—not just chemoinformatics and data sheets, but the tactile, practical confidence that comes from walking the production floor and seeing every step with one’s own eyes.
From the pilot plant bench to process optimization meetings, EMMTMI demonstrates the impact a well-made, thoroughly vetted intermediate has on the pace and certainty of project outcomes. The substance fills a need identified not just by market research but by conversations with those striving to shorten development timelines or manage large-scale production risks. Our commitment centers on delivering more than just a molecule; we ensure a partnership that lasts through the twists of both scientific discovery and industrial production. With every drum or bottle of EMMTMI leaving our site, we reaffirm our place not as traders or middlemen, but as makers with skin in the game, accountable for what we sell.